Larvol Delta - BioPath-Holdings-Provides-Update-from-Phase-11b-Clinical-Trial-of-BP1002-for-Treatment-of-RefractoryRelapsed-Acute-Myeloid-Leukemia

BP1002 - Bio-Path

https://www.globenewswire.com/news-release/2025/02/12/3025403/0/en/Bio-Path-Holdings-Provides-Update-from-Phase-1-1b-Clinical-Trial-of-BP1002-for-Treatment-of-Refractory-Relapsed-Acute-Myeloid-Leukemia.html

Feb 12, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next